Dr. Qais Mekki joined Reistone in 2020 as Senior Vice President, Head of International Development, US Site Head.
Qais has gained experience in the Pharmaceutical Industry for more than 30 years.Prior to joining Reistone, he served at Takeda for about 16 years as VP, Head of Clinical Science, Marketed Products; VP, Portfolio Strategy, Global Portfolio Management; VP, Head of Clinical Science for the Asia Pacific Region; VP, Head of Global Medical Safety, and Head of USA Pharmacovigilance; VP, Head of Biological Sciences, including Translational Medicine, Clinical Pharmacology, and Nonclinical Safety and Efficacy; and VP, Clinical Science. Before that, he worked in Fujisawa Healthcare for 14 years, and served as Senior Director, Medical Affairs; Medical Director Clinical Research; Director, Head of Clinical Pharmacology; and Associate Director, Clinical Studies, Internal Medicine.
Dr. Mekki received his Medical Degree from the University of Baghdad and PhD. in Clinical Pharmacology from the University of London.